<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>james-kirkland on AndArds</title>
    <link>https://andards.com/tags/james-kirkland/</link>
    <description>Recent content in james-kirkland on AndArds</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Fri, 27 Mar 2026 19:56:00 +0000</lastBuildDate><atom:link href="https://andards.com/tags/james-kirkland/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>The Hit and Run Approach to Senolytics: Why You Shouldn&#39;t Take Them Daily</title>
      <link>https://andards.com/posts/the-hit-and-run-approach-to-senolytics-why-you-shouldnt-take-them-daily/</link>
      <pubDate>Fri, 27 Mar 2026 19:56:00 +0000</pubDate>
      
      <guid>https://andards.com/posts/the-hit-and-run-approach-to-senolytics-why-you-shouldnt-take-them-daily/</guid>
      <description>Senolytics are a class of compounds designed to selectively eliminate senescent cells—often called &amp;ldquo;zombie cells&amp;rdquo;—from the body. These cells accumulate with age and contribute to various age-related conditions. While the concept of clearing these problematic cells is compelling, the optimal way to use senolytics isn&amp;rsquo;t a simple daily pill.</description>
    </item>
    
    <item>
      <title>James Kirkland&#39;s Senolytic Protocol: The Dasatinib and Quercetin Trials</title>
      <link>https://andards.com/posts/james-kirklands-senolytic-protocol-the-dasatinib-and-quercetin-trials/</link>
      <pubDate>Tue, 03 Mar 2026 04:28:00 +0000</pubDate>
      
      <guid>https://andards.com/posts/james-kirklands-senolytic-protocol-the-dasatinib-and-quercetin-trials/</guid>
      <description>The concept of &amp;ldquo;senolytics&amp;rdquo; has gained significant attention in the pursuit of understanding and potentially mitigating age-related conditions. At the forefront of this research is Dr. James Kirkland and his team at the Mayo Clinic, whose work has largely centered on identifying and testing compounds that selectively eliminate senescent cells—often referred to as &amp;ldquo;zombie cells.</description>
    </item>
    
    <item>
      <title>James Kirkland&#39;s Dasatinib and Quercetin Trials: The Mayo Clinic Senolytic Protocol</title>
      <link>https://andards.com/posts/james-kirklands-dasatinib-and-quercetin-trials-the-mayo-clinic-senolytic-protocol/</link>
      <pubDate>Wed, 25 Feb 2026 07:14:00 +0000</pubDate>
      
      <guid>https://andards.com/posts/james-kirklands-dasatinib-and-quercetin-trials-the-mayo-clinic-senolytic-protocol/</guid>
      <description>The exploration of aging and age-related diseases has led researchers to focus on senescent cells, often called &amp;ldquo;zombie cells.&amp;rdquo; These cells stop dividing but remain metabolically active, secreting inflammatory molecules that can damage surrounding healthy tissue. Dr.</description>
    </item>
    
    <item>
      <title>James Kirkland&#39;s Senolytics: Should You Be Taking Dasatinib and Quercetin?</title>
      <link>https://andards.com/posts/james-kirklands-senolytics-should-you-be-taking-dasatinib-and-quercetin/</link>
      <pubDate>Thu, 15 Jan 2026 03:47:00 +0000</pubDate>
      
      <guid>https://andards.com/posts/james-kirklands-senolytics-should-you-be-taking-dasatinib-and-quercetin/</guid>
      <description>The idea of &amp;ldquo;clearing zombie cells&amp;rdquo; to slow aging and improve health has captured significant attention. This concept revolves around senolytics – compounds designed to selectively eliminate senescent cells, often called &amp;ldquo;zombie cells&amp;rdquo; because they stop dividing but remain metabolically active, secreting inflammatory molecules that can harm surrounding healthy tissue.</description>
    </item>
    
  </channel>
</rss>
